Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020)
Cartesian Therapeutics (RNAC) reported Long-Term Debt Issuances of -$102,000 for Q4 2020.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020) Analysis & Trends
For FY2020, Cartesian Therapeutics posted Long-Term Debt Issuances of $24.74 million.
- Long-Term Debt Issuances has a five-year compound annual growth rate of 28.4% (FY2015 to FY2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,152.37 Bn | 1,120.96 Bn | 19.71 Bn | 8.94 Bn |
| 2 | Johnson & Johnson | 628.86 Bn | 547.39 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.37 Bn | 473.48 Bn | 12.70 Bn | - |
| 4 | Merck | 374.01 Bn | 328.39 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.56 Bn | 264.55 Bn | 11.24 Bn | 1.98 Bn |
| 6 | Astrazeneca | 263.92 Bn | 237.60 Bn | 12.86 Bn | - |
| 7 | Amgen | 238.37 Bn | 193.77 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 192.21 Bn | 166.40 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn | - |
| 10 | Cartesian Therapeutics | 187.71 Mn | -347.06 Mn | - | - |
API Access
Cartesian Therapeutics Long-Term Debt Issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-issuances", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();